Neurochemical Research

, Volume 35, Issue 3, pp 495–502

Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model

  • Jianjun Wu
  • Wenbo Yu
  • Yan Chen
  • Yaru Su
  • Zhengtong Ding
  • Huimin Ren
  • Yuping Jiang
  • Jian Wang
Original Paper

DOI: 10.1007/s11064-009-0086-6

Cite this article as:
Wu, J., Yu, W., Chen, Y. et al. Neurochem Res (2010) 35: 495. doi:10.1007/s11064-009-0086-6

Abstract

The potential value of glial cell line-derived neurotrophic factor (GDNF) in treating Parkinson's disease (PD) remains controversial. In order to evaluate the therapeutic effect of GDNF-engineered bone marrow stromal cells (BMSCs) in parkinsonian rat model, GDNF-BMSCs and LacZ-BMSCs were transplanted into striatum and followed by Lactacystin lesioning at median forebrain bundles 1 week later. We observed that the intrastriatal transplantation of GDNF-BMSCs could significantly rescue the dopaminergic neurons from lactacystin-induced neurotoxicity with regard to behavioral recovery, tyrosine hydroxylase level in nigra and striatum, and striatal dopamine level. We interpret the outcomes that intrastriatal transplantation of GDNF-BMSCs might be beneficial in the treatment of PD.

Keywords

Parkinson’s diseaseGlial cell line-derived neurotrophic factorLentivirusGene therapyBone marrow stromal cellsLactacystin

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jianjun Wu
    • 1
  • Wenbo Yu
    • 1
  • Yan Chen
    • 1
  • Yaru Su
    • 1
  • Zhengtong Ding
    • 1
  • Huimin Ren
    • 1
  • Yuping Jiang
    • 1
  • Jian Wang
    • 1
  1. 1.Department of NeurologyHuashan Hospital Affiliated to Fudan UniversityShanghaiPeople’s Republic of China